| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | May 31, 2023 | GeneDx Holdings Corp. | CFO | Sell | 47.5 | -2,296 | -1.10% | ✗ | $3K |
| Aug 8, 2022 | Aug 10, 2022 | GeneDx Holdings Corp. | Other | Sell | 46.3 | -20,245 | -7.66% | ✗ | $40.2K |
| May 8, 2022 | May 12, 2022 | GeneDx Holdings Corp. | CFO | Sell | 46.3 | -19,515 | -8.82% | ✗ | $48K |
| Apr 6, 2022 | Apr 8, 2022 | GeneDx Holdings Corp. | CFO | Sell | 50.0 | -1,284 | -0.80% | ✗ | $3.7K |
| Feb 8, 2022 | Feb 10, 2022 | GeneDx Holdings Corp. | CFO | Sell | 42.5 | -21,735 | -12.22% | ✗ | $78.2K |
| Dec 1, 2021 | Dec 3, 2021 | GeneDx Holdings Corp. | CFO | Sell | 60.0 | +403 | 0.35% | ✗ | $1.2K |
| Nov 29, 2021 | Dec 1, 2021 | GeneDx Holdings Corp. | CFO | Sell | 42.5 | -12,115 | -9.53% | ✗ | $80.3K |
| Nov 8, 2021 | Nov 10, 2021 | GeneDx Holdings Corp. | CFO | Sell | 42.5 | -19,516 | -13.31% | ✗ | $165.7K |
| Oct 25, 2021 | Nov 2, 2021 | GeneDx Holdings Corp. | CFO | Sell | 40.0 | -40,848 | -32.68% | ✗ | $308K |